RCR proffered paper session


Room: Room 3B

Rectal and bladder dose-volume relationships during image-guided radiotherapy for prostate cancer
Immunohistochemical assessment of cellular proliferation marker Ki67 in relation to prostate radiotherapy fractionation and prognosis in Trans-CHHiP.
Predicting lung fitness for radiotherapy from a CT scan
Patient weight loss and shrinkage during radical radiotherapy for head and neck cancer (HNC) does not increase risk of higher spinal cord dose.
Development and validation of a 28-gene hypoxia signature for localised prostate cancer